BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2423796)

  • 1. Antihypertensive therapy in the Federal Republic of Germany: clinical practice experience with indoramin (Wydora).
    Grube E; Giesing M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S43-7. PubMed ID: 2423796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive therapy with indoramin in the elderly.
    Deitch MW; Allen IE; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S88-92. PubMed ID: 2423807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
    Stannard M; Cohen M; Marrott PK; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S48-52. PubMed ID: 2423797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G; Korn A
    Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension.
    Stokes GS; Frost GW; Graham RM; MacCarthy EP
    Clin Pharmacol Ther; 1979 Jun; 25(6):783-9. PubMed ID: 36250
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
    Luomanmäki K; Hartikainen M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S63-7. PubMed ID: 2423800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effects of indoramin and prazosin in combination with hydrochlorothiazide.
    Solomon R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S56-62. PubMed ID: 2423799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
    Overlack A; Stumpe KO
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S53-5. PubMed ID: 2423798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoramin in the treatment of hypertension: a placebo controlled trial.
    Ramirez J
    Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoramin as an antihypertensive agent in the treatment of essential hypertension. A multicentre trial.
    Bednarek MR; Schoeman HS
    S Afr Med J; 1983 Mar; 63(11):398-400. PubMed ID: 6338603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
    Marshall AJ; Kettle MA; Barritt DW
    Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
    Antani J; Buckle JW; Turner J; Cohen M
    Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study comparing indoramin and propranolol in the treatment of black patients with hypertension.
    Bennett JM; Weich DJ; Schoeman HS
    S Afr Med J; 1988 Dec; 74(12):619-21. PubMed ID: 3061032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
    Holmes B; Sorkin EM
    Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of indoramin and methyldopa in hypertension.
    Rosendorff C
    S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoramin in the treatment of hypertension. A mini-review and update.
    Archibald JL; Turner P
    S Afr Med J; 1983 Feb; 63(9):307-9. PubMed ID: 6338605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoramin in the hypertensive diabetic patient.
    Sood VP; Stannard M; Beastall G; Weir RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S80-3. PubMed ID: 2423805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-adrenoreceptor blockade with indoramin in hypertension.
    Gould BA; Mann S; Davies AB; Altman DG; Raftery EB
    J Cardiovasc Pharmacol; 1983; 5(3):343-8. PubMed ID: 6191130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind comparison of indoramin with clonidine in the treatment of moderate to severe essential hypertension.
    Yajnik BH; Shah JS
    J Assoc Physicians India; 1985 May; 33(5):339-43. PubMed ID: 3900029
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of indoramin therapy on BP, renal function, and body fluid composition.
    Bauer JH; Jones LB; Gaddy P
    Arch Intern Med; 1984 Feb; 144(2):308-12. PubMed ID: 6696567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.